Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

OWASSO MEDICAL FACILITY, INC

NPI: 1144231432 · OWASSO, OK 74055 · General Acute Care Hospital · NPI assigned 08/11/2006

$3.35M
Total Medicaid Paid
35,996
Total Claims
34,426
Beneficiaries
31
Codes Billed
2018-01
First Month
2024-11
Last Month

Provider Details

Authorized OfficialPHILLIPS, DAVID (CHIEF EXECUTIVE OFFICER)
Parent OrganizationST. JOHN HEALTH SYSTEM
NPI Enumeration Date08/11/2006

Related Entities

Other providers sharing the same authorized official: PHILLIPS, DAVID

ProviderCityStateTotal Paid
ST JOHN SAPULPA, INC. SAPULPA OK $6.85M
HARRISON COMMUNITY HOSPITAL, INC. CADIZ OH $4.66M
BARNESVILLE HOSPITAL ASSOCIATION, INC. BARNESVILLE OH $3.14M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 2,977 $319K
2019 3,096 $315K
2020 1,877 $198K
2021 5,337 $516K
2022 9,832 $858K
2023 9,799 $871K
2024 3,078 $276K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99283 Emergency department visit for the evaluation and management, moderate severity 10,828 10,754 $1.80M
99284 Emergency department visit for the evaluation and management, high severity 2,049 2,007 $530K
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 1,038 1,029 $384K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2,158 2,128 $304K
99282 Emergency department visit for the evaluation and management, low to moderate severity 981 978 $96K
80053 Comprehensive metabolic panel 4,236 4,149 $58K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 5,047 4,941 $32K
96375 Therapeutic injection; each additional sequential IV push 1,031 995 $31K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 2,060 1,022 $29K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 531 529 $25K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 157 156 $11K
83605 1,116 1,018 $11K
71045 Radiologic examination, chest; single view 615 614 $8K
74177 Computed tomography, abdomen and pelvis; with contrast material 39 39 $7K
71046 Radiologic examination, chest; 2 views 400 396 $6K
96361 Intravenous infusion, hydration; each additional hour 196 193 $6K
81025 531 527 $4K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 123 122 $3K
81003 346 344 $2K
83690 416 410 $2K
81001 788 781 $2K
70450 Computed tomography, head or brain; without contrast material 36 36 $2K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 283 283 $1K
84484 82 78 $853.93
87807 57 57 $672.03
J2405 Injection, ondansetron hydrochloride, per 1 mg 602 591 $231.80
36415 Collection of venous blood by venipuncture 65 65 $230.91
83735 13 13 $77.48
J7030 Infusion, normal saline solution , 1000 cc 108 107 $0.00
J1170 Injection, hydromorphone, up to 4 mg 12 12 $0.00
J1885 Injection, ketorolac tromethamine, per 15 mg 52 52 $0.00